Talibov, V. O.; Fabini, E.; FitzGerald, E.; Tedesco, D.; Eriksson, D.; Talu,
M. J.; Rachman, M. M.; Mihalic, F.; Manoni, E.; Naldi, M.; Others. Discovery of
an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase. Chembiochem
2021, 22.

Parenti, M. D.; Naldi, M.; Manoni, E.; Fabini, E.; Cederfelt, D.; Talibov, V.
O.; Gressani, V.; Guven, U.; Grossi, V.; Fasano, C.; Others. Discovery of the
4-Aminopiperidine-Based Compound EM127 for the Site-Specific Covalent Inhibition
of SMYD3. Eur. J. Med. Chem. 2022, 114683.

Mitchell, L. H.; Boriack-Sjodin, P. A.; Smith, S.; Thomenius, M.; Rioux, N.;
Munchhof, M.; Mills, J. E.; Klaus, C.; Totman, J.; Riera, T. V.; Raimondi, A.;
Jacques, S. L.; West, K.; Foley, M.; Waters, N. J.; Kuntz, K. W.; Wigle, T. J.;
Scott, M. P.; Copeland, R. A.; Smith, J. J.; Chesworth, R. Novel Oxindole
Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small
Molecule SMYD3 Inhibitor. ACS Med. Chem. Lett. 2016, 7 (2), 134–138.

Luttens, A.; Gullberg, H.; Abdurakhmanov, E.; Vo, D. D.; Akaberi, D.; Talibov,
V. O.; Nekhotiaeva, N.; Vangeel, L.; De Jonghe, S.; Jochmans, D.; Others.
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with
Broad-Spectrum Activity against Coronaviruses. J. Am. Chem. Soc. 2022, 144 (7),
2905–2920.

